Page 2 of Sun pharma industries News: Sun pharma industries Latest News, Sun pharma industries Today news, Sun pharma industries Breaking News

Indian stock market, Motilal Oswal report, India vs emerging markets

Markets end on a stable note but Nifty closes below 24,100, Sensex up 600 points; Sun Pharma the big star in trading today

Sensex climbs 639 points, Nifty ends below 24,100 led by Sun Pharma; explore today’s top market movers and global cues!

Updated: April 27, 2026 15:38 IST

Coforge and Vodafone Idea share price rally midday India

Sharp slide: Markets clock worst 3-day slump since mid-march, Sensex, Nifty end week with 2% losses; Tech cracks

Sensex and Nifty closed over 1% lower amid IT stock declines and global market caution; explore key movers and sector…

Updated: April 24, 2026 15:46 IST

Tech Mahindra Q4 result: Profit up 20% sequentially, revenue growth aided by favourable currency exchange

Tech Mahindra reports 20.5% sequential rise in Q4 profit with revenue beating estimates, while margins improve and strong deal wins…

Updated: April 22, 2026 18:47 IST

Sensex today, Nifty today, GIFT Nifty today, stock market today, Indian stock market today

Markets end in the red: Nifty closes below 23,200; Sensex down 100 points, HDFC Bank, Titan see sharp cut

Sensex and Nifty closed slightly lower amid broad sectoral weakness—see which stocks moved and track market trends now.

Updated: April 16, 2026 15:34 IST

HSBC India Underweight rating April 2026 stock market impact

Cipla to Sun Pharma: Nomura rates these 6 pharma stocks, riding the GLP-1 wave, ‘Buy’

The Indian Pharmaceutical Market (IPM) grew 10.1% year-on-year in March 2026, according to the report. Pricing contributed 5.5% to growth,…

Updated: April 15, 2026 15:21 IST

Sensex today, Nifty 500 today, why market is rising today, why some stocks falling today

Why are these 9 stocks falling even as Sensex, Nifty surge over 3% each

Discover which 9 Nifty stocks slipped despite Sensex and Nifty surging—read now for reasons and stock details!

April 8, 2026 14:36 IST

Ceasefire hopes push indices higher

Benchmark indices Sensex and Nifty surged over 1% as ceasefire hopes in the Middle East lifted global sentiment, stabilised crude…

April 6, 2026 18:54 IST

Aurobindo Pharma announces Rs 800 crore buyback

Aurobindo Pharma plans Rs 800 crore buyback: Know price, record date, key details

Aurobindo Pharma’s Rs 800 crore buyback: Key date set—what investors should check.

Updated: April 6, 2026 11:00 IST

Only two large-cap stocks hit a perfect Piotroski score in 2026. (AI-generated image from Gemini)

2 Large-cap stocks with a perfect Piotroski score

Two pharma largecaps—Sun Pharmaceutical Industries Ltd. and Torrent Pharmaceuticals Ltd.—score a perfect 9 on Piotroski, backed by strong financials, growth,…

April 4, 2026 05:30 IST

kotak it sector report tcs infosys tech mahindra coforge outlook

TCS, Infosys, Tech Mahindra, Coforge: Kotak Institutional Equities’ top IT sector picks ahead of Q4 results

Kotak sees IT slowdown ahead but backs TCS, Infosys, Tech Mahindra, Coforge as deal momentum and AI shifts reshape growth.

April 3, 2026 12:30 IST

Precious metals tumble, aluminium hits 4-year high amid Iran tensions; India tightens gold import rules

Metal prices whipsaw as Iran conflict escalates, India tightens gold import rules.

April 3, 2026 12:30 IST

US announced 100% tariffs on patented drugs.

Will Trump’s 100% pharma tariff hit India’s $10.5 billion generic business? 1-year window explained

US President Donald Trump’s 100% tariff plan on patented drugs, generics remain exempt for now; here’s what it means for…

Updated: April 3, 2026 16:40 IST

ICICI Bank, HDFC Bank, AU Small Finance Bank, Motilal Oswal top banking picks

Axis Securities’ top 5 picks for April with up to 46% upside potential

Market correction has reset valuations but Axis sees select stocks with strong upside and earnings visibility ahead.

Updated: April 3, 2026 10:15 IST

A financial chart showing Kalpataru Projects' 20-25% revenue CAGR for Power T&D, its Rs 600 crore payment recovery from the Water business, and Emkay’s target price of Rs 1,450.

Kalpataru Projects: Emkay sees 36% upside – West Asia risk low, data cetres driving growth

Emkay Global retains Buy on KPIL with a target of Rs 1,450, citing strong T&D growth drivers; discover if this…

April 3, 2026 08:53 IST

sun pharma us tariff exposure jefferies report

US Tariff concerns: Jefferies explains why Sun Pharma could face the biggest hit—But not the worst outcome

Sun Pharma may be the most exposed to US tariffs but a global buffer could quietly limit the real damage.

April 3, 2026 07:55 IST

India to double S-400 fleet? Inside Russia's Rs 50,000 cr bid for 5 additional squadrons

BEL, HAL, Garden Reach, L&T: Why Rs 2.38 trillion defence deal approval can be a gamechanger

India approves Rs 2.38 trillion defence deals, spotlighting BEL, HAL, L&T, and GRSE—track these stocks for future order wins!

April 2, 2026 14:14 IST

Stocks making biggest moves midday: Glenmark, Aurobindo Pharma, Sun Pharma,IndiGo, Sai Parenteral and more

A sharp sell-off gripped markets as pharma stocks plunged on US tariff fears and rising crude prices dragged key sectors,…

April 2, 2026 13:04 IST

bharat electronics stock outlook fy26 order inflow defence

Bharat Electronics: Nomura sees Rs 6 lk cr order windfall by FY27 but maintains ‘Neutral’ – Here’s why

Strong BEL order inflows impress Street, but rich valuations keep upside limited as Nomura stays cautious.

April 2, 2026 11:58 IST

Page 2 of Sun Pharmaceutical Industries

Related News

Trending Topics